Peter Grogg
No más puestos en curso
Perfil
El Dr. Peter Grogg es presidente de Ingro Finanz AG. Forma parte del Consejo de Administración de Kenta Biotech AG y Bachem Holding AG. Anteriormente, el Dr. Grogg fue vicepresidente del Consejo de Supervisión de Sunstar-Holding AG, vicepresidente de Dottikon Es Holding AG, director general de Bachem AG, socio de Fox-Chemicals GmbH, director de Ciba Holding AG, presidente de MFC Beteiligungs AG y presidente de Pevion Biotech AG. También formó parte del consejo de administración de Berna Biotech AG, GABA AG y Polyphor AG.
Antiguos cargos conocidos de Peter Grogg.
| Empresas | Cargo | Fin |
|---|---|---|
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Engages in the research, development, production, and marketing of biotechnological and pharmaceutical products | Director/Miembro de la Junta | 02/06/2025 |
| BACHEM HOLDING AG | Presidente | 01/01/2012 |
Ingro Finanz AG
 Ingro Finanz AG Financial ConglomeratesFinance Provides investment services | Presidente | 02/06/2025 |
| DOTTIKON ES HOLDING AG | Director/Miembro de la Junta | 06/07/2012 |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Director Ejecutivo | 01/01/2002 |
Formación de Peter Grogg.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
9
Relaciones de 1er grado
14
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 14 |
|---|---|
Ciba Holding AG
 Ciba Holding AG Chemicals: Major DiversifiedProcess Industries Manufactures and distributes chemicals, pigments, adhesives, sealants, paints, coatings, plastics and resins | Process Industries |
Berna Biotech AG
 Berna Biotech AG Miscellaneous Commercial ServicesCommercial Services Produces and develops immunobiological preparations | Commercial Services |
Bachem Holding AG
 Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Sunstar-Holding AG
 Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Operates hotels | Consumer Services |
Ingro Finanz AG
Ingro Finanz AG Financial ConglomeratesFinance Provides investment services | Finance |
GABA AG
 GABA AG Medical DistributorsDistribution Services Distributes dental oral care products | Distribution Services |
Dottikon ES Holding AG
 Dottikon ES Holding AG Chemicals: SpecialtyProcess Industries Operates as a holding company with interest in manufacturing of chemicals, intermediates and active pharmaceutical ingredients | Process Industries |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
Pevion Biotech AG
 Pevion Biotech AG Pharmaceuticals: MajorHealth Technology Develops efficient and safe vaccines based on proprietary technology | Health Technology |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Engages in the research, development, production, and marketing of biotechnological and pharmaceutical products | Health Technology |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Health Technology |
Fox-Chemicals GmbH | |
MFC Beteiligungs AG |
- Bolsa de valores
- Insiders
- Peter Grogg
